Factors related to outcome of bloodstream infections due to Candida parapsilosis complex

Sentinel surveillance of invasive candidiasis in Spain: epidemiology and antifungal susceptibility

(2015) M.C. Nieto et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Epidemiology, clinical characteristics, and outcome of candidemia in a tertiary referral center in Italy from 2010 to 2014

(2015) Francesco Barchiesi et al.   INFECTION

Clinical characteristics and treatment outcomes of patients with candidaemia due toCandida parapsilosis sensu latospecies at a medical centre in Taiwan, 2000–12

(2015) Chien-Yuan Chen et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Initial Use of Echinocandins Does Not Negatively Influence Outcome in Candida parapsilosis Bloodstream Infection: A Propensity Score Analysis

(2014) Mario Fernández-Ruiz et al.   CLINICAL INFECTIOUS DISEASES

Candidaemia in internal medicine departments: the burden of a rising problem

(2013) M. Bassetti et al.   CLINICAL MICROBIOLOGY AND INFECTION

Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA Project)

(2013) M. T. Montagna et al.   INFECTION

A 1-year prospective survey of candidemia in Italy and changing epidemiology over one decade

(2013) A. M. Tortorano et al.   INFECTION

Clinical impact of time to positivity for Candida species on mortality in patients with candidaemia

(2013) S.-H. Kim et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Epidemiology of Candidemia in Latin America: A Laboratory-Based Survey

(2013) Marcio Nucci et al.   PLoS One

Candida and Host Determinants of Susceptibility to Invasive Candidiasis

(2013) Michail S. Lionakis et al.   PLoS Pathogens

Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials

(2012) D. R. Andes et al.   CLINICAL INFECTIOUS DISEASES

ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients

(2012) O.A. Cornely et al.   CLINICAL MICROBIOLOGY AND INFECTION

Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012

(2012) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Emerging trends in candidemia: A higher incidence but a similar outcome

(2012) J. Fortún et al.   JOURNAL OF INFECTION

Prospective Multicenter Study of the Epidemiology, Molecular Identification, and Antifungal Susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis Isolated from Patients with Candidemia

(2011) Emilia Cantón et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria

(2011) M.A. Pfaller et al.   DRUG RESISTANCE UPDATES

Characterization of Candida parapsilosis complex strains isolated from invasive fungal infections

(2011) E. Borghi et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America

(2009) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

Candida parapsilosis, an Emerging Fungal Pathogen

(2008) D. Trofa et al.   CLINICAL MICROBIOLOGY REVIEWS